FOIAengine: How Lilly, Novo Nordisk, Others Use FOIA Welcome to 2025. At PoliScio Analytics, we logged 45,720 federal FOIA requests into our FOIAengine database during the past 12 months. But one subject, more than most others, dominated in hundreds of requests from hedge funds, pharmaceutical companies, and the news media: GLP-1 weight-loss drugs. This week, we're taking a closer look at what some of those GLP-1 requesters wanted to know during the past year. We last covered the weight-loss revolution when it was just getting started. (See our May 3, 2023 story, " Riding the Ozempic Wave .") Since then, there's been a surge in weight-loss FOIA requests, as seen clearly in FOIAengine, which tracks FOIA requests in as close to real-time as their availability allows.